Evaluation of a cervical cancer screening program based on HPV testing and LLETZ excision in a low resource setting

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  McAdam, Margaret ^a   Sakita, Jerol ^b   Tarivonda, Len ^b   Pang, James ^a   Frazer, Ian H ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Ministry of Health   (Vanuatu)

Author keywords

[No Author keywords available]

Indexed keywords

LUGOL;

ADULT; ARTICLE; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY TEST; LOOP ELECTROSURGICAL EXCISION OF THE CERVIX TRANSITION ZONE; MAJOR CLINICAL STUDY; PHYSICAL EXAMINATION; PILOT STUDY; PREDICTION; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERUS BIOPSY; UTERUS SURGERY; WART VIRUS; ALPHAPAPILLOMAVIRUS; BIOPSY; EVALUATION; ISOLATION AND PURIFICATION; MASS SCREENING; MIDDLE AGED; PATHOLOGY; STANDARD; UTERINE CERVIX TUMOR; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; BIOPSY; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 78049282863     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013266     Document Type: Article

References (25)

1. Smith RA, Cokkinides V, Brawley OW (2009) Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 59: 27-41. 59/1/27 [pii];10.3322/caac.20008 [doi].
2. Grce M (2009) Primary and secondary prevention of cervical cancer. Expert Rev Mol Diagn 9: 851-857. 10.1586/erm.09.64 [doi].
3. (1996) Cervical cancer control in developing countries: memorandum from a WHO meeting. Bull World Health Organ 74: 345-351.
4. Sankaranarayanan R, Wesley R, Thara S, Dhakad N, Chandralekha B, et al. (2003) Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer 106: 404-408. 10.1002/ijc.11245 [doi].
5. Shastri SS, Dinshaw K, Amin G, Goswami S, Patil S, et al. (2005) Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ 83: 186-194. S0042-96862005000300011 [pii];/S0042-96862005000300011 [doi].
6. Arbyn M, Sankaranarayanan R, Muwonge R, Keita N, Dolo A, et al. (2008) Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India. Int J Cancer 123: 153-160. 10.1002/ijc.23489 [doi].
7. Wright TC Jr (2003) Chapter 10: Cervical cancer screening using visualization techniques. J Natl Cancer Inst Monogr. pp 66-71.
8. Denny L, Kuhn L, De SM, Pollack AE, Dupree W, Wright TC Jr (2005) Screenand-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 294: 2173-2181. 294/17/2173 [pii];10.1001/jama.294.17.2173 [doi].
9. Chirenje ZM, Rusakaniko S, Akino V, Mlingo M (2001) A randomised clinical trial of loop electrosurgical excision procedure (LEEP) versus cryotherapy in the treatment of cervical intraepithelial neoplasia. J Obstet Gynaecol 21: 617-621. M3UREXKC4D7CQ4WH [pii];10.1080/01443610120085618 [doi].
10. Garland SM, Brotherton JM, Skinner SR, Pitts M, Saville M, et al. (2008) Human papillomavirus and cervical cancer in Australasia and Oceania: riskfactors, epidemiology and prevention. Vaccine 26 Suppl 12: M80-M88. S0264-410X(08)00630-0 [pii];10.1016/j.vaccine.2008.05.041 [doi].
11. Sankaranarayanan R, Wesley RS (2003) A practical manual on visual screening for cervical neoplasia. 1-49 Lyon, IARC Press.
12. McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, et al. (2008) Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 9: 425-434. S1470-2045(08)70103-7 [pii];10.1016/S1470-2045(08)70103-7 [doi].
13. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla PP, et al. (2010) Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 11: 249-257. S1470-2045(09)70360-2 [pii];10.1016/S1470-2045(09)70360-2 [doi].
14. [Anonymous] (2005) Screening to Prevent Cervical Cancer: Guidelines for the Management of Asymptomatic Women with Screen Detected Abnormalities.
15. Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, et al. (2006) Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 108: 264-272. 108/2/264 [pii];10.1097/01.AOG.0000220505.18525.85 [doi].
16. Pretorius RG, Zhang X, Belinson JL, Zhang WH, Ren SD, et al. (2006) Distribution of cervical intraepithelial neoplasia 2, 3 and cancer on the uterine cervix. J Low Genit Tract Dis 10: 45-50. 00128360-200601000-00008 [pii].
17. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, et al. (2009) HPV screening for cervical cancer in rural India. N Engl J Med 360: 1385-1394. 360/14/1385 [pii];10.1056/NEJMoa0808516 [doi].
18. Mitchell H (2005) Outcome after a cervical cytology report of low-grade squamous abnormality in Australia. Cancer 105: 185-193. 10.1002/cncr.21181 [doi].
19. Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J (2006) Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 24 Suppl 3: S3-78-S3/89. S0264-410X(06)00722-5 [pii];10.1016/j.vaccine.2006.05.117 [doi].
20. Cibas ES, Hong X, Crum CP, Feldman S (2007) Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples. Gynecol Oncol 104: 702-706. S0090-8258(06)00890-0 [pii];10.1016/j.ygyno.2006.10.048 [doi].
21. Jarmulowicz MR, Jenkins D, Barton SE, Goodall AL, Hollingworth A, Singer A (1989) Cytological status and lesion size: a further dimension in cervical intraepithelial neoplasia. Br J Obstet Gynaecol 96: 1061-1066.
22. Tidbury P, Singer A, Jenkins D (1992) CIN 3: the role of lesion size in invasion. Br J Obstet Gynaecol 99: 583-586.
23. Furber SE, Weisberg E, Simpson JM (1997) Progression and regression of lowgrade epithelial abnormalities of the cervix. Aust N Z J Obstet Gynaecol 37: 107-112.
24. Sankaranarayanan R, Keshkar V, Kothari A, Kane S, Fayette JM, Shastri S (2009) Effectiveness and safety of loop electrosurgical excision procedure for cervical neoplasia in rural India. Int J Gynaecol Obstet 104: 95-99. S0020-7292(08)00431-1 [pii];10.1016/j.ijgo.2008.09.009 [doi].
25. Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, et al. (2005) The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 97: 1072-1079. 97/14/1072 [pii];10.1093/jnci/dji187 [doi].